DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced RPS (ReSearch Pharmaceutical Services, Inc.) selected DATATRAK as a preferred vendor and joined DATATRAK's CRO Connect Partner™ program. RPS is a global Contract Research Organization (CRO) with more than 3,000 employees operating in 45 countries.
"RPS is excited to announce that it has selected DATATRAK as one of its preferred vendors in order to maximize the benefit and minimize the cost in using DATATRAK's unified software suite, DATATRAK ONE™," stated Daniel Perlman, RPS CEO and Chairman. "We strongly believe that the industry leading solutions of RPS, combined with DATATRAK's robust Technology solution will bring our customers excellent quality, data integrity and responsiveness at a highly competitive price. After several years of experience working together, this seemed to be the next logical step in enhancing our combined offering."
"RPS is a great new addition to our CRO Connect Partner™ program, and we are excited to be providing them the most powerful SaaS clinical research platform in the world," stated Laurence P. Birch, DATATRAK's Chairman of the Board and CEO. "This partnership was a natural progression as a result of our work with RPS on client studies and their participation in our Product Advisory Council. We look forward to continued growth for both companies."
Do gut microbes cause autism? New research says diet plays the bigger role